Skip to main content

Table 2 Time schedule of the trial

From: A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

Days Day 0 Day 1 Day 2 Day 3 Day 7 Day 28
End point Inclusion    Primary end point   Secondary end point
Antithrombin 30 IU/kg 30 IU/kg 30 IU/kg    
Evaluation A,B,C,D,E Antithrombin Antithrombin A,B,C,E A,B,C F
  Antithrombin    Antithrombin Antithrombin Mortality
  1. A-F, refer to Methods in the text.